Funding Instruments · Part 3 of 4
SAFE vs Convertible Note vs Priced Round: What They Are, How They Differ, and Which to Use
Three ways to raise, three sets of trade-offs. A clear comparison of SAFEs, convertible notes and priced rounds, and a simple guide to which fits your stage, your amount and your investors.
In this guide
In the US, the market has largely settled this question. As of Q1 2026, SAFEs made up 93% of pre-seed rounds and convertible notes just 7%, according to Carta. But two things keep the decision alive. First, “most US pre-seed founders use a SAFE” is not the same as “you should” - the right instrument depends on your stage, your amount and your investors. Second, that US consensus does not travel: in Africa, debt made up 41% of all tech capital in 2025 (Partech), so notes and other structures are far more common than the US numbers suggest.
There are three main answers to how the money comes in: a SAFE, a convertible note, or a priced round. This post lays out the trade-offs and gives you a simple way to choose the one that actually fits your situation.
The three instruments in one line each
- A SAFE is a promise of future equity: money now, shares at your next priced round, no valuation set today, no debt.
- A convertible note is a loan that converts: money now, shares later, but with interest ticking and a maturity date attached.
- A priced round sets a valuation today and issues shares immediately: everyone knows exactly what they own the day it closes.
The first two delay the valuation; the third sets it now. That single difference drives most of the trade-offs below.
The comparison
| Feature | SAFE | Convertible note | Priced round |
|---|---|---|---|
| What it is | Promise of future equity | Loan that converts to equity | Immediate sale of shares |
| Is it debt? | No | Yes, accrues interest | No, it is equity |
| Valuation set now? | No, deferred to next round | No, deferred to next round | Yes, set today |
| Maturity date | None | Yes, usually 18 to 24 months | Not applicable |
| Speed to close | Fastest, days | Fast, days to weeks | Slowest, weeks to months |
| Legal cost | Lowest | Low to moderate | Highest |
| Certainty on ownership | Low until conversion | Low until conversion | High, known on day one |
| Typical stage | Pre-seed, seed | Pre-seed, seed | Series A and beyond, strong seeds |
| Best for | Speed and simplicity | Investors wanting protection | Large rounds, a lead investor |
Read down the “certainty” and “speed” rows together and the core trade-off appears: SAFEs and notes buy you speed and low cost at the price of not knowing your exact dilution until later; a priced round buys you certainty and formal structure at the price of time, money and a valuation you have to defend.
When to use a SAFE
Reach for a SAFE when you are early, the round is small, and speed matters. At pre-seed and much of seed, you often cannot defend a real valuation anyway, and forcing that argument just slows you down. A SAFE lets you collect cheques as investors say yes, without waiting to close everyone at once. The discipline, as we cover in the SAFE post, is to track the total dilution your SAFEs will create, because their ease hides their cumulative bite.
When to use a convertible note
Reach for a convertible note when an investor specifically wants the protection that debt gives, interest and a maturity date, or when local law and lawyers understand notes better than SAFEs. In several African markets, a note is the faster instrument to close simply because it maps onto conventional loan documentation that local advisers already know. The cost is the maturity date, which becomes a real fundraising deadline you must manage against your runway.
When to do a priced round
Do a priced round when the amount is large, when a lead investor wants the certainty of a set valuation and formal shareholder rights, or when you have enough traction to defend a real number. This is standard from Series A onward, and increasingly common at well-supported seed rounds. A priced round costs more and takes longer, because it involves a real valuation negotiation and a term sheet with proper rights and protections. In return, everyone knows exactly what they own, and the messy uncertainty of multiple converting instruments disappears.
A simple decision guide
If you want a rule of thumb, use these three questions in order.
- How much are you raising, and how fast? Small and fast points to a SAFE. Large points to a priced round.
- What does your lead investor want? If they want the protection of debt, a note. If they want the certainty and control of formal shareholding, a priced round. If they are happy to move quickly on standard terms, a SAFE.
- Can you defend a real valuation? If yes, and the round is sizeable, a priced round rewards you with certainty. If not, defer the valuation with a SAFE or note.
There is no universally correct answer, only the right fit for your situation. Many companies use a SAFE or note early and their first priced round at Series A, which is exactly the pattern the funding ladder describes.
The African lens
Two local realities should weigh on your choice. First, familiarity: SAFEs are increasingly known but notes are often more comfortable for local angels and lawyers, so the instrument that closes fastest may be the one your investor’s advisers already understand. Second, currency: because most rounds are struck in dollars while founders earn in local currency, any instrument that defers conversion also defers the moment your dilution is fixed in local terms, and a weakening currency can make that deferred cost heavier, so factor the currency risk into how long you leave instruments outstanding. Whichever you choose, get it adapted to your actual jurisdiction of incorporation rather than lifted from a foreign template.
The bottom line
Do not pick an instrument because it is fashionable. Pick it because it fits how much you are raising, what your investors want, and whether you can defend a valuation yet. Get the fit right and the paperwork disappears into the background, which is exactly where it belongs. When you move to a priced round, the document that governs it is the term sheet, and understanding its clauses is the next thing every founder should learn.
FAQ
Frequently asked questions
Should a startup use a SAFE, a convertible note or a priced round?
It depends on stage and size. SAFEs suit fast, small, early rounds. Notes suit early rounds where the investor wants the protection of debt or local lawyers prefer them. Priced rounds suit larger rounds, usually Series A and beyond, where a lead investor wants certainty and you can defend a real valuation.
What is the main difference between a SAFE and a priced round?
A priced round sets a valuation and issues shares immediately, so everyone knows exactly what they own on day one. A SAFE delays the valuation and converts into shares later at your next priced round. Priced rounds are more work and cost more to close; SAFEs are faster and cheaper but leave dilution uncertain until conversion.
Why do investors sometimes prefer convertible notes over SAFEs?
Because a note is debt. It accrues interest and has a maturity date, which gives the investor more protection and leverage than a SAFE. In some markets, including parts of Africa, notes are also more familiar to local lawyers and map onto existing loan documentation.
When should you do a priced round instead of a SAFE?
When the amount is large, when a lead investor wants the certainty of a set valuation and formal shareholder rights, or when you have enough traction to defend a real valuation. Priced rounds are standard from Series A onward and increasingly common at well-supported seed rounds.
